Johan van Griensven

Summary

Publications

  1. pmc Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care
    Johan van Griensven
    Medecins Sans Frontieres, Kigali, Rwanda
    BMC Pediatr 8:39. 2008
  2. doi request reprint Weight loss after the first year of stavudine-containing antiretroviral therapy and its association with lipoatrophy, virological failure, adherence and CD4 counts at primary health care level in Kigali, Rwanda
    Johan van Griensven
    Medecins Sans Frontieres, Operational Centre Brussels, Medical Department, Duprestraat 94, 1090 Brussels, Belgium
    Trans R Soc Trop Med Hyg 104:751-7. 2010
  3. ncbi request reprint High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda
    Johan van Griensven
    Medecins Sans Frontieres, Kimihurura, Kacyiru, 1361 Kigali, Rwanda
    Trans R Soc Trop Med Hyg 101:793-8. 2007
  4. doi request reprint Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda
    Johan van Griensven
    Medecins Sans Frontieres, Operational Centre Brussels, Medical Department, Duprestraat 94, 1090 Brussels, Belgium
    Trans R Soc Trop Med Hyg 104:148-53. 2010
  5. doi request reprint Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir
    Johan van Griensven
    Medecins Sans Frontieres, Kigali, Rwanda
    Trans R Soc Trop Med Hyg 103:613-9. 2009
  6. pmc Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda
    Fabienne Shumbusho
    Family Health International, Kigali, Rwanda
    PLoS Med 6:e1000163. 2009
  7. doi request reprint Supporting 'medicine at a distance' for delivery of hospital services in war-torn Somalia: how well are we doing?
    Abdisalan M Maalim
    Medecins Sans Frontieres, Belgium, Somalia Mission Coordination, Nairobi, Kenya
    Int Health 6:70-3. 2014
  8. doi request reprint Symptomatic hyperlactatemia: lessons learned using a point-of-care device in a health care center- and nurse-based antiretroviral program in Rwanda
    Johan van Griensven
    Clin Infect Dis 46:320-2; author reply 322. 2008
  9. doi request reprint Increased baseline body weight is a risk factor associated with virological failure while on antiretroviral treatment
    Johan van Griensven
    J Acquir Immune Defic Syndr 48:631-3. 2008
  10. ncbi request reprint Hematopoietic stem cell-based gene therapy against HIV infection: promises and caveats
    Johan van Griensven
    Rega Institute for Medical Research, K U Leuven and Kulak, Leuven, Belgium
    AIDS Rev 7:44-55. 2005

Collaborators

Detail Information

Publications11

  1. pmc Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care
    Johan van Griensven
    Medecins Sans Frontieres, Kigali, Rwanda
    BMC Pediatr 8:39. 2008
    ....
  2. doi request reprint Weight loss after the first year of stavudine-containing antiretroviral therapy and its association with lipoatrophy, virological failure, adherence and CD4 counts at primary health care level in Kigali, Rwanda
    Johan van Griensven
    Medecins Sans Frontieres, Operational Centre Brussels, Medical Department, Duprestraat 94, 1090 Brussels, Belgium
    Trans R Soc Trop Med Hyg 104:751-7. 2010
    ..In low-income countries, measuring weight is a routine clinical procedure that could be used to filter out individuals with lipoatrophy on stavudine-based ART, after alternative causes of weight loss have been ruled out...
  3. ncbi request reprint High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda
    Johan van Griensven
    Medecins Sans Frontieres, Kimihurura, Kacyiru, 1361 Kigali, Rwanda
    Trans R Soc Trop Med Hyg 101:793-8. 2007
    ..Lipoatrophy appears to be an important long-term complication of WHO-recommended first-line ART regimens. These data highlight the urgent need for access to more affordable and less toxic ART regimens in resource-limited settings...
  4. doi request reprint Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda
    Johan van Griensven
    Medecins Sans Frontieres, Operational Centre Brussels, Medical Department, Duprestraat 94, 1090 Brussels, Belgium
    Trans R Soc Trop Med Hyg 104:148-53. 2010
    ..d4T is associated with significant long-term toxicity. d4T-dose reduction, increased access to safer ART in low-income countries and close monitoring for those at risk are all relevant strategies...
  5. doi request reprint Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir
    Johan van Griensven
    Medecins Sans Frontieres, Kigali, Rwanda
    Trans R Soc Trop Med Hyg 103:613-9. 2009
    ..The weight loss with zidovudine might justify earlier substitution and access to better alternatives like tenofovir/abacavir...
  6. pmc Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda
    Fabienne Shumbusho
    Family Health International, Kigali, Rwanda
    PLoS Med 6:e1000163. 2009
    ..We retrospectively evaluated the feasibility and effectiveness of this task-shifting model using descriptive data...
  7. doi request reprint Supporting 'medicine at a distance' for delivery of hospital services in war-torn Somalia: how well are we doing?
    Abdisalan M Maalim
    Medecins Sans Frontieres, Belgium, Somalia Mission Coordination, Nairobi, Kenya
    Int Health 6:70-3. 2014
    ..We describe an innovative strategy implemented to support national staff at Istarlin Hospital in the conflict setting of Somalia; and report on inpatient morbidities, mortality and adverse hospital exit outcomes...
  8. doi request reprint Symptomatic hyperlactatemia: lessons learned using a point-of-care device in a health care center- and nurse-based antiretroviral program in Rwanda
    Johan van Griensven
    Clin Infect Dis 46:320-2; author reply 322. 2008
  9. doi request reprint Increased baseline body weight is a risk factor associated with virological failure while on antiretroviral treatment
    Johan van Griensven
    J Acquir Immune Defic Syndr 48:631-3. 2008
  10. ncbi request reprint Hematopoietic stem cell-based gene therapy against HIV infection: promises and caveats
    Johan van Griensven
    Rega Institute for Medical Research, K U Leuven and Kulak, Leuven, Belgium
    AIDS Rev 7:44-55. 2005
    ..Hence, the extent to which these alterations hamper a gene therapy approach, or can be reversed upon HAART, will determine the feasibility of future gene therapy against AIDS...
  11. ncbi request reprint Expression of HIV-1 integrase in CEM cells inhibits HIV-1 replication
    Johan van Griensven
    Rega Institute for Medical Research, Minderbroedersstraat 10, B 3000 Leuven, Belgium
    J Gene Med 6:268-77. 2004
    ..We now have constructed CEM-derived cell lines stably expressing the enzyme or its different domains and studied the impact of IN expression on HIV-1 replication...